TORONTO, June 10, 2013 /CNW/ - MedCannAccess welcomes the Marihuana for
Medical Purposes Regulations released today by Health Canada.
"These reforms reduce red tape, allowing Canadians more timely access to
their medicine. Opening the medical cannabis industry to competition
will allow us to provide improved patient care across the country,"
said Blaine Dowdle, CEO.
MedCannAccess welcomes a number of the reforms:
Simplifying the application process to decrease wait times and improve
access for patients
Allowing an unlimited number of strains of medical marihuana, increasing
Allowing patients to choose their provider
Allowing the importation of medical cannabis genetics
Allowing the exportation of medical marihuana
Ability to conduct R&D, positioning Canada as a leader in medical
"These regulations will greatly improve patient access to medical
marihuana. Health Canada projects that the number of authorized
patients will grow 10 fold to 300 000 within 10 years." said Rade
Kovacevic, Chief Business Development Officer. "MedCannAccess looks
forward to operating within the new regulatory environment and the
opportunity to provide its products and expertise internationally."
MedCannAccess strongly believes that access to affordable healthcare is
a cornerstone of Canadian values. "In the short term we believe that
affordability will remain a concern for patients, however, in the long
term we believe that economies of scale and innovations will reduce the
cost of this necessary medical product," said Kevin Furet, Chief
MedCannAccess is established to provide access to the highest-quality of
medical cannabis products developed through research and innovation,
improving the quality of life for persons with chronic disabilities and
terminal illnesses. MedCannAccess is a proud member of the Toronto
Board of Trade, Guelph Chamber of Commerce and Ontario Chamber of
For further information:
Media Contact: Rade Kovacevic, CBDO: 519-780-7830
8437726 Canada Inc. MedCannAccess